BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 18756257)

  • 41. Cigarette Smoking and Subtypes of Uncontrolled Blood Pressure Among Diagnosed Hypertensive Patients: Paradoxical Associations and Implications.
    Liu X; Byrd JB
    Am J Hypertens; 2017 Jun; 30(6):602-609. PubMed ID: 28203691
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influence of age and hypertension treatment-time on ambulatory blood pressure in hypertensive patients.
    Hermida RC; Ayala DE; Crespo JJ; Mojón A; Chayán L; Fontao MJ; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):176-91. PubMed ID: 23077974
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term Outcomes of the Effects of Home Blood Pressure Telemonitoring and Pharmacist Management on Blood Pressure Among Adults With Uncontrolled Hypertension: Follow-up of a Cluster Randomized Clinical Trial.
    Margolis KL; Asche SE; Dehmer SP; Bergdall AR; Green BB; Sperl-Hillen JM; Nyboer RA; Pawloski PA; Maciosek MV; Trower NK; O'Connor PJ
    JAMA Netw Open; 2018 Sep; 1(5):e181617. PubMed ID: 30646139
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level--the "normotensive non-dipper" paradox.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):87-98. PubMed ID: 23039824
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of Intensive Blood Pressure Lowering on Incident Atrial Fibrillation and P-Wave Indices in the ACCORD Blood Pressure Trial.
    Chen LY; Bigger JT; Hickey KT; Chen H; Lopez-Jimenez C; Banerji MA; Evans G; Fleg JL; Papademetriou V; Thomas A; Woo V; Seaquist ER; Soliman EZ
    Am J Hypertens; 2016 Nov; 29(11):1276-1282. PubMed ID: 26476086
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ambulatory blood pressure and risk of new-onset atrial fibrillation in treated hypertensive patients.
    Coccina F; Pierdomenico AM; Ianni U; De Rosa M; De Luca A; Pirro D; Pizzicannella J; Trubiani O; Cipollone F; Renda G; Pierdomenico SD
    J Clin Hypertens (Greenwich); 2021 Jan; 23(1):147-152. PubMed ID: 33242233
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ambulatory Blood Pressure Characteristics and Long-Term Risk for Atrial Fibrillation.
    Perkiömäki JS; Nortamo S; Ylitalo A; Kesäniemi A; Ukkola O; Huikuri HV
    Am J Hypertens; 2017 Mar; 30(3):264-270. PubMed ID: 27852579
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Systolic Blood Pressure Visit-to-Visit Variability and Major Adverse Outcomes in Atrial Fibrillation: The AFFIRM Study (Atrial Fibrillation Follow-Up Investigation of Rhythm Management).
    Proietti M; Romiti GF; Olshansky B; Lip GYH
    Hypertension; 2017 Nov; 70(5):949-958. PubMed ID: 28974568
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The LIFE Study.
    Wachtell K; Gerdts E; Aurigemma GP; Boman K; Dahlöf B; Nieminen MS; Olsen MH; Okin PM; Palmieri V; Rokkedal JE; Devereux RB
    Blood Press; 2010 Jun; 19(3):169-75. PubMed ID: 20438307
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension.
    Okin PM; Wachtell K; Devereux RB; Harris KE; Jern S; Kjeldsen SE; Julius S; Lindholm LH; Nieminen MS; Edelman JM; Hille DA; Dahlöf B
    JAMA; 2006 Sep; 296(10):1242-8. PubMed ID: 16968848
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modifiable Risk Factors for Incident Heart Failure in Atrial Fibrillation.
    Chatterjee NA; Chae CU; Kim E; Moorthy MV; Conen D; Sandhu RK; Cook NR; Lee IM; Albert CM
    JACC Heart Fail; 2017 Aug; 5(8):552-560. PubMed ID: 28624486
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Systolic blood pressure and mortality in patients with atrial fibrillation and heart failure: insights from the AFFIRM and AF-CHF studies.
    Tremblay-Gravel M; Khairy P; Roy D; Leduc H; Wyse DG; Cadrin-Tourigny J; Macle L; Dubuc M; Andrade J; Rivard L; Guerra PG; Thibault B; Ahmed A; Talajic M; Guertin MC; White M
    Eur J Heart Fail; 2014 Nov; 16(11):1168-74. PubMed ID: 25296634
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Electrocardiographic left atrial abnormalities and risk of incident stroke in hypertensive patients with electrocardiographic left ventricular hypertrophy.
    Okin PM; Kamel H; Kjeldsen SE; Devereux RB
    J Hypertens; 2016 Sep; 34(9):1831-7. PubMed ID: 27254312
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Atrial Fibrillation Detection During 24-Hour Ambulatory Blood Pressure Monitoring: Comparison With 24-Hour Electrocardiography.
    Kollias A; Destounis A; Kalogeropoulos P; Kyriakoulis KG; Ntineri A; Stergiou GS
    Hypertension; 2018 Jul; 72(1):110-115. PubMed ID: 29735633
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Systolic Blood Pressure and Effects of Screening for Atrial Fibrillation With Long-Term Continuous Monitoring (a LOOP Substudy).
    Xing LY; Diederichsen SZ; Højberg S; Krieger DW; Graff C; Olesen MS; Brandes A; Køber L; Haugan KJ; Svendsen JH
    Hypertension; 2022 Sep; 79(9):2081-2090. PubMed ID: 35862138
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association among blood pressure control in elderly patients with hypertension, left atrial structure and function and new-onset atrial fibrillation: a prospective 2-year study in 234 patients.
    Watanabe T; Kawasaki M; Tanaka R; Ono K; Nishigaki K; Takemura G; Arai M; Noda T; Watanabe S; Minatoguchi S
    Hypertens Res; 2013 Sep; 36(9):799-806. PubMed ID: 23552515
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increased arterial stiffness is an independent predictor of atrial fibrillation in hypertensive patients.
    Cremer A; Lainé M; Papaioannou G; Yeim S; Gosse P
    J Hypertens; 2015 Oct; 33(10):2150-5. PubMed ID: 26431194
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Upstream therapeutic strategies of Valsartan and Fluvastatin on Hypertensive patients with non-permanent Atrial Fibrillation (VF-HT-AF): study protocol for a randomized controlled trial.
    Qi WW; Liu T; Xu G; Li LF; Liang YZ; Ye L; Li GP
    Trials; 2015 Aug; 16():336. PubMed ID: 26248619
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diagnostic accuracy of a novel cuffless self-blood pressure monitor for atrial fibrillation screening in the elderly.
    Kyriakoulis KG; Kollias A; Anagnostopoulos I; Gravvani A; Kalogeropoulos P; Destounis A; Stergiou GS
    J Clin Hypertens (Greenwich); 2019 Dec; 21(12):1797-1802. PubMed ID: 31742911
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Relationship of sudden cardiac death to new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy.
    Okin PM; Bang CN; Wachtell K; Hille DA; Kjeldsen SE; Dahlöf B; Devereux RB
    Circ Arrhythm Electrophysiol; 2013 Apr; 6(2):243-51. PubMed ID: 23403268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.